Enterprise Value
298M
Cash
76.21M
Avg Qtr Burn
N/A
Short % of Float
15.20%
Insider Ownership
9.31%
Institutional Own.
54.05%
Qtr Updated
06/30/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
TPOXX (Intravenous) Details Smallpox, Vaccine | Approved Update | |
TPOXX® (tecovirimat) Details Smallpox | Approved Quarterly sales |